First Time Loading...

LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 65.46 USD 3.92% Market Closed
Updated: Apr 27, 2024
Section:
 

Relative Value

The Relative Value of one LMAT stock under the Base Case scenario is 57.17 USD. Compared to the current market price of 65.46 USD, LeMaitre Vascular Inc is Overvalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LMAT Relative Value
Base Case
57.17 USD
Overvaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.6
P/S
P/S
Price to Sales
7.6
vs History
25
vs Industry
18
Median 3Y
6.9
Median 5Y
6.5
Industry
2.4
Forward
6.8
More Details
48.5
P/E
P/E
Price to Earnings
48.5
vs History
25
vs Industry
10
Median 3Y
44.4
Median 5Y
40.3
Industry
23.2
Forward
38.8
More Details
39.8
P/OCF
P/OCF
Price to OCF
39.8
vs History
38
vs Industry
9
Median 3Y
34.5
Median 5Y
34.6
Industry
15.5
More Details
49.6
P/FCFE
P/FCFE
Price to FCFE
49.6
vs History
36
vs Industry
12
Median 3Y
44.5
Median 5Y
44.5
Industry
23.5
More Details
4.9
P/B
P/B
Price to Book Value
4.9
vs History
26
vs Industry
17
Median 3Y
4.3
Median 5Y
4.3
Industry
2.2
More Details
7
EV/S
EV/S
Enterprise Value to Sales
7
vs History
25
vs Industry
18
Median 3Y
6.4
Median 5Y
6
Industry
2.5
Forward
6.3
More Details
10.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.7
vs History
25
vs Industry
21
Median 3Y
9.8
Median 5Y
9.3
Industry
5.2
More Details
29
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
29
vs History
12
vs Industry
10
Median 3Y
24.9
Median 5Y
23.5
Industry
12.5
Forward
22.9
More Details
36.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
36.5
vs History
12
vs Industry
11
Median 3Y
31.3
Median 5Y
30.2
Industry
17.2
Forward
29.9
More Details
36.9
EV/OCF
EV/OCF
Enterprise Value to OCF
36.9
vs History
39
vs Industry
10
Median 3Y
31.9
Median 5Y
32.2
Industry
15.1
More Details
46
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
46
vs History
34
vs Industry
11
Median 3Y
36.2
Median 5Y
41.2
Industry
19.7
More Details
5.7
EV/IC
EV/IC
Enterprise Value to IC
5.7
vs History
11
vs Industry
15
Median 3Y
4.7
Median 5Y
4.6
Industry
2
More Details

Multiples Across Competitors

LMAT Competitors Multiples
LeMaitre Vascular Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
LeMaitre Vascular Inc
NASDAQ:LMAT
1.5B USD 7.6 48.5 29 36.5
US
Abbott Laboratories
NYSE:ABT
186.5B USD 4.6 33.1 19.5 29
US
Intuitive Surgical Inc
NASDAQ:ISRG
133.1B USD 18.2 67 54.9 68.9
US
Stryker Corp
NYSE:SYK
127.6B USD 6.2 40.3 25.1 31.1
US
Boston Scientific Corp
NYSE:BSX
107.2B USD 7.5 68.3 31.7 47.3
IE
Medtronic PLC
NYSE:MDT
106B USD 3.3 25.2 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
66.9B USD 3.4 54.9 18.4 38.9
DE
Siemens Healthineers AG
XETRA:SHL
59.1B EUR 2.7 38.9 18.6 31.4
US
Edwards Lifesciences Corp
NYSE:EW
52B USD 8.7 37 26.8 29
US
Dexcom Inc
NASDAQ:DXCM
47.9B USD 13.2 88.5 59.6 77.6
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
349.3B CNY 10.2 30.8 26.7 26.7

See Also

Summary
LMAT intrinsic value, competitors valuation, and company profile.
DCF Valuation
LMAT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LMAT stock valuation using valuation multiples.
Wall Street Estimates
LMAT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LMAT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.